Details for New Drug Application (NDA): 212779
✉ Email this page to a colleague
NDA 212779 describes POTASSIUM CITRATE, which is a drug marketed by Ut Sw Medctr, Ani Pharms, Ascent Pharms Inc, Bionpharma, Hibrow Hlthcare, Rising, Strides Pharma, Teva Pharms Usa Inc, Torrent, and Zydus Pharms, and is included in ten NDAs. It is available from fourteen suppliers. Additional details are available on the POTASSIUM CITRATE profile page.
The generic ingredient in POTASSIUM CITRATE is potassium citrate. There are two hundred and forty drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.
The generic ingredient in POTASSIUM CITRATE is potassium citrate. There are two hundred and forty drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.
Summary for 212779
| Tradename: | POTASSIUM CITRATE |
| Applicant: | Ani Pharms |
| Ingredient: | potassium citrate |
| Patents: | 0 |
Pharmacology for NDA: 212779
| Mechanism of Action | Acidifying Activity Calcium Chelating Activity |
| Physiological Effect | Decreased Coagulation Factor Activity |
Medical Subject Heading (MeSH) Categories for 212779
Suppliers and Packaging for NDA: 212779
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 212779 | ANDA | ANI Pharmaceuticals, Inc. | 62559-291 | 62559-291-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62559-291-01) |
| POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 212779 | ANDA | ANI Pharmaceuticals, Inc. | 62559-292 | 62559-292-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62559-292-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MEQ | ||||
| Approval Date: | Jan 14, 2020 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 15MEQ | ||||
| Approval Date: | Jan 14, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
